Matches in SemOpenAlex for { <https://semopenalex.org/work/W1836111884> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W1836111884 endingPage "40" @default.
- W1836111884 startingPage "437" @default.
- W1836111884 abstract "Intravenous drug abuse is often associated with poor adherence to anti-retroviral drugs in HIV/AIDS. Very few studies in Pakistan have determined implications of intravenous drug abuse on anti-retroviral drug compliance in HIV/AIDS patients. The objectives of the study were to assess and compare the adherence to anti-retroviral drugs in intravenous drug users (IDUs) and non-intravenous drug users (NIDUs) and to determine various factors influencing the adherence to anti-retroviral (ARV) drugs in HIV positive IDUs in HIV treatment centre Pakistan Institute of Medical Sciences (PIMS), Islamabad.This descriptive observational study was carried out at HIV/AIDS treatment and care centre PIMS, Islamabad. A total of 162 HIV positive male (81 IDU and 81 NIDU) were enrolled in this study. They were followed over a period of five years from 2008-2012. ARV drug compliance and anti-tuberculosis treatment (ATT) outcome in IDUs and NIDUs were assessed using standard outcome parameters.Among IDUs Hepatitis C was positive in 63 (77.77%) cases and negative in 18 (22.22%) cases. In NIDUs hepatitis C was positive in 5 (6.17%) and negative in 76 (93.82%) (p=0.000). In IDUs Pulmonary tuberculosis was present in 61 (75.30%) patients and in NIDUs it was present in 52 (64.19%) (p=0.171). Regarding ATT outcome, amongst IDUs 41 (50.61%) lost to follow up, 16 (19.75%) were compliant to treatment and 4 (4.93%) were transferred out. In NIDUs, 2 (2.46%) patients were lost to follow-up, 38 (46.91%) remained compliant to treatment and 6 (7.40%) were transferred out (p=0.000). Regarding end status of ARVs, in IDUs, 48 (59.25%) were lost to follow-up, 1 (1.23%) was defaulter, 16 (19.75%) were compliant to treatment, 8 (9.87%) were transferred out and 8 (9.87%) expired. In NIDUs, 73 (90.12%) were compliant to treatment, 5 (6.17%) expired, 2 (2.46%) were lost to follow-up.Due to various socioeconomic and clinical factors, compliance to ARVs in IDUs is poorer as compared to NIDUs. The factors recognized are illiteracy, poor socioeconomic status, unemployment and various comorbidities (Hepatitis B, C and Tuberculosis) which are more prevalent in IDUs." @default.
- W1836111884 created "2016-06-24" @default.
- W1836111884 creator A5025771106 @default.
- W1836111884 creator A5029535437 @default.
- W1836111884 creator A5039767151 @default.
- W1836111884 date "2015-02-13" @default.
- W1836111884 modified "2023-09-23" @default.
- W1836111884 title "Anti-retroviral drugs compliance in intravenous and non intravenous drug abusers." @default.
- W1836111884 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25672159" @default.
- W1836111884 hasPublicationYear "2015" @default.
- W1836111884 type Work @default.
- W1836111884 sameAs 1836111884 @default.
- W1836111884 citedByCount "4" @default.
- W1836111884 countsByYear W18361118842015 @default.
- W1836111884 countsByYear W18361118842018 @default.
- W1836111884 crossrefType "journal-article" @default.
- W1836111884 hasAuthorship W1836111884A5025771106 @default.
- W1836111884 hasAuthorship W1836111884A5029535437 @default.
- W1836111884 hasAuthorship W1836111884A5039767151 @default.
- W1836111884 hasConcept C118552586 @default.
- W1836111884 hasConcept C126322002 @default.
- W1836111884 hasConcept C142724271 @default.
- W1836111884 hasConcept C159047783 @default.
- W1836111884 hasConcept C23131810 @default.
- W1836111884 hasConcept C2776455275 @default.
- W1836111884 hasConcept C2780035454 @default.
- W1836111884 hasConcept C2780727368 @default.
- W1836111884 hasConcept C2781069245 @default.
- W1836111884 hasConcept C3013748606 @default.
- W1836111884 hasConcept C3019645122 @default.
- W1836111884 hasConcept C40010229 @default.
- W1836111884 hasConcept C71924100 @default.
- W1836111884 hasConcept C98274493 @default.
- W1836111884 hasConceptScore W1836111884C118552586 @default.
- W1836111884 hasConceptScore W1836111884C126322002 @default.
- W1836111884 hasConceptScore W1836111884C142724271 @default.
- W1836111884 hasConceptScore W1836111884C159047783 @default.
- W1836111884 hasConceptScore W1836111884C23131810 @default.
- W1836111884 hasConceptScore W1836111884C2776455275 @default.
- W1836111884 hasConceptScore W1836111884C2780035454 @default.
- W1836111884 hasConceptScore W1836111884C2780727368 @default.
- W1836111884 hasConceptScore W1836111884C2781069245 @default.
- W1836111884 hasConceptScore W1836111884C3013748606 @default.
- W1836111884 hasConceptScore W1836111884C3019645122 @default.
- W1836111884 hasConceptScore W1836111884C40010229 @default.
- W1836111884 hasConceptScore W1836111884C71924100 @default.
- W1836111884 hasConceptScore W1836111884C98274493 @default.
- W1836111884 hasIssue "4" @default.
- W1836111884 hasLocation W18361118841 @default.
- W1836111884 hasOpenAccess W1836111884 @default.
- W1836111884 hasPrimaryLocation W18361118841 @default.
- W1836111884 hasRelatedWork W209233648 @default.
- W1836111884 hasRelatedWork W2103774485 @default.
- W1836111884 hasRelatedWork W2416997749 @default.
- W1836111884 hasRelatedWork W2444078905 @default.
- W1836111884 hasRelatedWork W2883854498 @default.
- W1836111884 hasRelatedWork W2912845607 @default.
- W1836111884 hasRelatedWork W2916971313 @default.
- W1836111884 hasRelatedWork W323211344 @default.
- W1836111884 hasRelatedWork W911606 @default.
- W1836111884 hasRelatedWork W2045370752 @default.
- W1836111884 hasVolume "26" @default.
- W1836111884 isParatext "false" @default.
- W1836111884 isRetracted "false" @default.
- W1836111884 magId "1836111884" @default.
- W1836111884 workType "article" @default.